Protecting the female germ line from cancer therapy.
Casper
R F
RF
Jurisicova
A
A
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000528:radiation effects; D005260:Female; D006801:Humans; D008246:Lysophospholipids; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D009865:Oocytes / Q000187:drug effects* / Q000528:radiation effects*; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D013108:Sphingomyelin Phosphodiesterase / Q000235:genetics / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D051028:bcl-2-Associated X Protein
D008246:Lysophospholipids; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D011837:Radiation-Protective Agents; D051028:bcl-2-Associated X Protein; C060506:sphingosine 1-phosphate; D013108:Sphingomyelin Phosphodiesterase; D013110:Sphingosine